Lab-Based IVD Market Size and Forecast 2025-2032
According to SNS Insider, the Lab-Based IVD Market size was valued at USD 42.54 billion in 2024 and is projected to reach USD 67.03 billion by 2032, expanding at a CAGR of 5.87% over the forecast period 2025–2032.
The global Lab-Based IVD (In Vitro Diagnostics) market is experiencing steady growth due to the increasing demand for accurate and timely disease diagnosis across healthcare systems worldwide. In-vitro diagnostics conducted in controlled laboratory settings continue to play a critical role in disease screening, monitoring, and therapeutic decision-making. The expansion of clinical testing applications, coupled with the growing burden of chronic and infectious diseases, has significantly strengthened the demand for lab-based diagnostic systems.
The market encompasses a wide range of product types, including instruments and reagents & consumables. Among these, reagents and consumables account for a significant revenue share due to their recurring usage and high-volume demand in diagnostic laboratories. By technique, immunodiagnostics and molecular diagnostics are emerging as dominant segments due to their increasing use in infectious disease testing, oncology, and genetic disorder screening.
Get a Free Sample Report of Lab-Based IVD Market @ https://www.snsinsider.com/sample-request/7677
Growth Drivers
A major factor propelling the growth of the Lab-Based IVD market is the advancement of molecular diagnostic techniques, which have revolutionized disease detection by enabling precise and early-stage diagnostics. Innovations in PCR (Polymerase Chain Reaction), next-generation sequencing (NGS), and isothermal amplification technologies are allowing laboratories to deliver high-throughput and highly sensitive testing results. These advancements are especially critical in areas such as oncology, infectious disease management, and prenatal screening.
Additionally, the increasing prevalence of infectious diseases such as influenza, tuberculosis, and COVID-19 has further reinforced the importance of laboratory-based testing, prompting governments and healthcare providers to invest in robust diagnostic infrastructure. Cardiovascular diseases, oncology-related conditions, and autoimmune disorders also represent significant diagnostic burdens that are fueling market expansion.
An aging global population, rising awareness of personalized medicine, and growing demand for point-of-care confirmation testing from centralized laboratories continue to contribute to market growth. Clinical laboratories and hospitals remain the leading end-users due to their access to comprehensive test menus and high-volume sample processing capabilities. Furthermore, the rising use of saliva, tissue, and urine samples in routine diagnostics is expanding the testable biomarker universe, enhancing diagnostic reach and reliability.
Key Market Segments
By Product Type: Instruments, Reagents & Consumables
By Technique: Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Hematology, Others
By Sample Type: Blood, Urine, Saliva, Tissue, Others
By Application: Infectious Diseases, Cardiology, Oncology, Gastroenterology, Allergy, Autoimmunity, Prenatal Screening, Others
By End-User: Hospitals, Clinical Laboratories, Others
Regional Trends
North America currently leads the Lab-Based IVD market, driven by robust healthcare infrastructure, high testing volumes, and continued investment in laboratory technologies. Europe follows closely, with increased adoption of molecular diagnostics and public health screening programs. The Asia-Pacific region is witnessing the fastest growth, supported by rising healthcare expenditure, improved access to diagnostics in urban and rural areas, and the expanding presence of multinational diagnostic companies.
Recent Developments
In March 2024, a leading diagnostics firm announced the global launch of a multiplex PCR platform that enables simultaneous detection of over 20 pathogens from a single sample, reducing testing time and improving workflow efficiencies in labs.
In September 2023, several public-private partnerships were formed across Southeast Asia to expand laboratory testing capacity in response to emerging infectious diseases and cancer screening demands.
Buy a Single-User PDF of Lab-Based IVD Market Analysis & Outlook Report @ https://www.snsinsider.com/checkout/7677
Outlook
The Lab-Based IVD Market is set to continue its upward trajectory, driven by the growing need for precise diagnostic insights, integration of automation and AI in laboratories, and a global shift toward preventive healthcare. As diagnostic workflows become more streamlined and personalized, the demand for high-performance lab-based IVD systems will remain a cornerstone of modern medical decision-making
Read Our Other Report
Artificial Intelligence (AI) in Pharmaceutical Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave – Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
